251 related articles for article (PubMed ID: 18165284)
1. The role of recombinant human insulin-like growth factor-I in treating children with short stature.
Collett-Solberg PF; Misra M;
J Clin Endocrinol Metab; 2008 Jan; 93(1):10-8. PubMed ID: 18165284
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-I (rhIGF-I) therapy of short stature.
Rosenbloom AL
J Pediatr Endocrinol Metab; 2008 Apr; 21(4):301-15. PubMed ID: 18556960
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human insulin-like growth factor-I therapy for children with growth disorders.
Richmond EJ; Rogol AD
Adv Ther; 2008 Dec; 25(12):1276-87. PubMed ID: 19066756
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations.
Clark RG
Horm Res; 2004; 62 Suppl 1():93-100. PubMed ID: 15761240
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
[TBL] [Abstract][Full Text] [Related]
6. Mecasermin (recombinant human insulin-like growth factor I).
Rosenbloom AL
Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone-resistant syndromes: long-term follow-up.
Chernausek SD
Endocr Dev; 2009; 14():135-42. PubMed ID: 19293580
[TBL] [Abstract][Full Text] [Related]
8. Recombinant IGF-I: Past, present and future.
Bright GM
Growth Horm IGF Res; 2016 Jun; 28():62-5. PubMed ID: 26822565
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
Kemp SF
BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167
[TBL] [Abstract][Full Text] [Related]
10. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity.
Chernausek SD; Backeljauw PF; Frane J; Kuntze J; Underwood LE;
J Clin Endocrinol Metab; 2007 Mar; 92(3):902-10. PubMed ID: 17192294
[TBL] [Abstract][Full Text] [Related]
12. A two year observation of the process of applying recombinant IGF-1 to treat short stature in children with primary IGF-1 deficiency -- case reports of 3 patients.
Petriczko E; Wikiera B; Horodnicka-Józwa A; Marcinkiewicz K; Szmit-Domagalska J; Kędzia A; Durzyńska J; Broniarczyk J; Gabryelczyk B; Noczyńska A; Walczak M
Pediatr Endocrinol Diabetes Metab; 2011; 17(4):233-8. PubMed ID: 22248785
[TBL] [Abstract][Full Text] [Related]
13. Principles of growth hormone and insulin-like growth factor-I treatment in children with idiopathic short stature.
Bang P
Horm Res Paediatr; 2011; 76 Suppl 3():24-6. PubMed ID: 21912155
[TBL] [Abstract][Full Text] [Related]
14. Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure.
Clark RG
Pediatr Nephrol; 2005 Mar; 20(3):290-4. PubMed ID: 15682316
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human insulin-like growth factor-1 treatment: ready for primetime.
Bright GM; Mendoza JR; Rosenfeld RG
Endocrinol Metab Clin North Am; 2009 Sep; 38(3):625-38. PubMed ID: 19717008
[TBL] [Abstract][Full Text] [Related]
16. A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I).
Bright GM; Fierro-Renoy JF
Growth Horm IGF Res; 2020 Jun; 52():101318. PubMed ID: 32252003
[TBL] [Abstract][Full Text] [Related]
17. Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial.
Midyett LK; Rogol AD; Van Meter QL; Frane J; Bright GM;
J Clin Endocrinol Metab; 2010 Feb; 95(2):611-9. PubMed ID: 19880790
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
Camacho-Hübner C; Rose S; Preece MA; Sleevi M; Storr HL; Miraki-Moud F; Minuto F; Frystyk J; Rogol A; Allan G; Sommer A; Savage MO
J Clin Endocrinol Metab; 2006 Apr; 91(4):1246-53. PubMed ID: 16403822
[TBL] [Abstract][Full Text] [Related]
19. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.
Nakae J; Kato M; Murashita M; Shinohara N; Tajima T; Fujieda K
J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572
[TBL] [Abstract][Full Text] [Related]
20. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.
Thrailkill K; Quattrin T; Baker L; Litton J; Dwigun K; Rearson M; Poppenheimer M; Kotlovker D; Giltinan D; Gesundheit N; Martha P
J Clin Endocrinol Metab; 1997 Apr; 82(4):1181-7. PubMed ID: 9100593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
